Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;99(2):115238.
doi: 10.1016/j.diagmicrobio.2020.115238. Epub 2020 Oct 15.

Sample pooling on the Cepheid Xpert® Xpress SARS-CoV-2 assay

Affiliations

Sample pooling on the Cepheid Xpert® Xpress SARS-CoV-2 assay

Maryza Graham et al. Diagn Microbiol Infect Dis. 2021 Feb.

Abstract

The COVID-19 pandemic has placed unprecedented global demand on laboratory supplies required for testing. Sample pooling has been investigated by laboratories as a strategy to preserve testing capacity. We evaluate the performance of Cepheid Xpert® Xpress SARS-CoV-2 RT-PCR assay for testing samples in pools of 4 and 6. Clinical samples containing SARS-CoV-2, and confirmed negative clinical samples were used to create sample pools. Clinical samples had 'neat' Xpert® E gene cycle threshold values ranging between 20 and 28 and all were detected qualitatively when contained in pools of 4 or 6 samples. For these samples, pooling had a median change in cycle threshold value of 2.0 in pools of 4, and of 2.9 in pools of 6. With the use of Cepheid Xpert® Xpress SARS-CoV-2 RT-PCR assay, pooling of 4 or 6 samples may be an effective strategy to increase testing capacity.

Keywords: Cepheid; GeneXpert; Pooling; SARS-CoV-2.

PubMed Disclaimer

Figures

Fig 1
Fig. 1
Standard curve of Xpert E gene Ct value and viral load.

References

    1. Loeffelholz M.J., Alland D., Butler-Wu S.M., Pandey U., Perno C.F., Nava A. Multicenter evaluation of the Cepheid Xpert Xpress SARS-CoV-2 test. J Clin Microbiol. 2020;58 e00926-20. - PMC - PubMed
    1. Moran A., Beavis K.G., Matushek S.M., Ciaglia C., Francois N., Tesic V. Detection of SARS-CoV-2 by use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche Cobas SARS-CoV-2 assays. J Clin Microbiol. 2020;58 e00772-20. - PMC - PubMed
    1. Lieberman J.A., Pepper G., Naccache S.N., Huang M.-.L., Jerome K.R., Greninger A.L. Comparison of commercially available and laboratory-developed assays for in vitro detection of SARS-CoV-2 in clinical laboratories. J Clin Microbiol. 2020;58 e00821-20. - PMC - PubMed
    1. Zhen W., Smith E., Manji R., Schron D., Berry G.J. Clinical evaluation of three sample-to-answer platforms for detection of SARS-CoV-2. J Clin Microbiol. 2020;58 e00783-20. - PMC - PubMed
    1. Wolters F., van de Bovenkamp J., van den Bosch B., van den Brink S., Broeders M., Chung N.H. Multi-center evaluation of Cepheid Xpert® Xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic. J Clin Virol. 2020;128 doi: 10.1016/j.jcv.2020.104426. - DOI - PMC - PubMed

MeSH terms